Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cell adhesion molecule binding	NPHS1 NRCAM ICAM3 OBSCN CDHR5 ADAMTS8 SLC3A2 THBS1 NEO1 DCHS1 IGSF9 ADAM17 SCRIB PLEC CDH6 NOS3 CDH15	1.61e-05	599	171	17	GO:0050839
GeneOntologyMolecularFunction	calcium ion binding	TRPM4 SGCA PCDHGA1 PCDHAC1 CDHR5 CBLB PKDREJ DNAH7 PCDH20 THBS1 FAT2 HMCN2 PCDH11X DCHS1 ASTN2 CDH6 PCDH9 CDH15	7.93e-05	749	171	18	GO:0005509
GeneOntologyMolecularFunction	RNA uridylyltransferase activity	TUT4 TUT1	2.18e-04	3	171	2	GO:0050265
GeneOntologyBiologicalProcess	cell-cell adhesion	EPHB4 NPHS1 NRCAM PCDHGA1 RC3H1 ICAM3 AKNA EPB41L5 MFSD2B PCDHAC1 CDHR5 CBLB LRG1 PCDH20 SLC7A1 THBS1 NEO1 FAT2 PBRM1 HMCN2 LRFN5 PCDH11X DCHS1 ROBO2 ASTN2 IGSF9 COL14A1 SCRIB PLEKHA7 CDH6 PCDH9 CDH15	1.65e-10	1077	168	32	GO:0098609
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	NRCAM PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 HMCN2 PCDH11X DCHS1 ROBO2 IGSF9 CDH6 PCDH9 CDH15	4.32e-10	187	168	14	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	NRCAM PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 HMCN2 LRFN5 PCDH11X DCHS1 ROBO2 IGSF9 CDH6 PCDH9 CDH15	4.45e-08	313	168	15	GO:0098742
GeneOntologyBiologicalProcess	response to mechanical stimulus	PDE2A DDR2 PDZD7 ATAT1 PKDREJ THBS1 KCNA5 PLEC SLITRK6 NOS3	3.63e-05	247	168	10	GO:0009612
GeneOntologyCellularComponent	anchoring junction	NPHS1 KIF23 ATP7B GIT1 SGCA DDR2 OBSCN OBSL1 EPB41L5 ATAT1 PRX SLC3A2 FAT2 KCNA5 ADAM17 SCRIB PLEC PLEKHA7 RPL4 CDH6 PCDH9 CDH15	1.94e-05	976	173	22	GO:0070161
Domain	FN3	EPHB4 NPHS1 IGFN1 NRCAM COL20A1 OBSCN OBSL1 FNDC4 NEO1 LRRN4CL LRFN5 ROBO2 ASTN2 IGSF9 COL14A1 IL9R	3.36e-11	199	168	16	PS50853
Domain	FN3_dom	EPHB4 NPHS1 IGFN1 NRCAM COL20A1 OBSCN OBSL1 FNDC4 NEO1 LRRN4CL LRFN5 ROBO2 ASTN2 IGSF9 COL14A1 IL9R	7.02e-11	209	168	16	IPR003961
Domain	FN3	EPHB4 NPHS1 IGFN1 NRCAM COL20A1 OBSCN OBSL1 FNDC4 NEO1 LRRN4CL ROBO2 ASTN2 IGSF9 COL14A1	1.33e-09	185	168	14	SM00060
Domain	fn3	EPHB4 NPHS1 IGFN1 NRCAM COL20A1 OBSCN OBSL1 FNDC4 NEO1 LRRN4CL ROBO2 IGSF9 COL14A1	2.57e-09	162	168	13	PF00041
Domain	Cadherin-like	SGCA PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 PCDH11X DCHS1 CDH6 PCDH9 CDH15	7.81e-09	116	168	11	IPR015919
Domain	Cadherin_CS	PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 PCDH11X DCHS1 CDH6 PCDH9 CDH15	5.25e-08	109	168	10	IPR020894
Domain	CADHERIN_1	PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 PCDH11X DCHS1 CDH6 PCDH9 CDH15	7.42e-08	113	168	10	PS00232
Domain	CADHERIN_2	PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 PCDH11X DCHS1 CDH6 PCDH9 CDH15	8.07e-08	114	168	10	PS50268
Domain	-	PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 PCDH11X DCHS1 CDH6 PCDH9 CDH15	8.07e-08	114	168	10	2.60.40.60
Domain	CA	PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 PCDH11X DCHS1 CDH6 PCDH9 CDH15	8.77e-08	115	168	10	SM00112
Domain	Cadherin	PCDHGA1 PCDHAC1 CDHR5 PCDH20 FAT2 PCDH11X DCHS1 CDH6 PCDH9 CDH15	1.12e-07	118	168	10	IPR002126
Domain	Ig-like_fold	IGSF8 EPHB4 NPHS1 IGFN1 NRCAM COL20A1 SGCA ICAM3 OBSCN OBSL1 FNDC4 FCRLA SIGLEC15 NEO1 HMCN2 LRRN4CL LRFN5 ROBO2 ASTN2 IGSF9 COL14A1 IL9R	3.89e-07	706	168	22	IPR013783
Domain	-	IGSF8 EPHB4 NPHS1 IGFN1 NRCAM COL20A1 SGCA ICAM3 OBSCN OBSL1 FNDC4 FCRLA SIGLEC15 NEO1 LRRN4CL LRFN5 ROBO2 ASTN2 IGSF9 COL14A1 IL9R	5.62e-07	663	168	21	2.60.40.10
Domain	Cadherin	PCDHGA1 PCDHAC1 PCDH20 FAT2 PCDH11X DCHS1 CDH6 PCDH9 CDH15	8.34e-07	113	168	9	PF00028
Domain	Ig_I-set	NPHS1 IGFN1 NRCAM OBSCN OBSL1 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	8.77e-06	190	168	10	IPR013098
Domain	I-set	NPHS1 IGFN1 NRCAM OBSCN OBSL1 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	8.77e-06	190	168	10	PF07679
Domain	IG	IGSF8 NPHS1 IGFN1 NRCAM ICAM3 OBSCN OBSL1 FCRLA SIGLEC15 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	2.83e-05	421	168	14	SM00409
Domain	Ig_sub	IGSF8 NPHS1 IGFN1 NRCAM ICAM3 OBSCN OBSL1 FCRLA SIGLEC15 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	2.83e-05	421	168	14	IPR003599
Domain	TSPN	COL20A1 TSPEAR THBS1 COL14A1	4.89e-05	23	168	4	SM00210
Domain	IGc2	NPHS1 IGFN1 NRCAM OBSCN OBSL1 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	5.45e-05	235	168	10	SM00408
Domain	Ig_sub2	NPHS1 IGFN1 NRCAM OBSCN OBSL1 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	5.45e-05	235	168	10	IPR003598
Domain	IG_LIKE	IGSF8 NPHS1 IGFN1 NRCAM ICAM3 OBSCN OBSL1 FCRLA SIGLEC15 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	1.46e-04	491	168	14	PS50835
Domain	Laminin_G	COL20A1 TSPEAR THBS1 FAT2 COL14A1	1.73e-04	58	168	5	IPR001791
Domain	Ig-like_dom	IGSF8 NPHS1 IGFN1 NRCAM ICAM3 OBSCN OBSL1 FCRLA SIGLEC15 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	1.88e-04	503	168	14	IPR007110
Domain	Galactose-bd-like	EPHB4 HECTD3 DDR2 AEBP1 NPRL3 SUCO	2.05e-04	94	168	6	IPR008979
Domain	Cadherin_2	PCDHGA1 PCDHAC1 PCDH20 PCDH11X PCDH9	2.96e-04	65	168	5	PF08266
Domain	Cadherin_N	PCDHGA1 PCDHAC1 PCDH20 PCDH11X PCDH9	2.96e-04	65	168	5	IPR013164
Domain	P5-ATPase	ATP13A4 ATP13A2	4.77e-04	4	168	2	PF12409
Domain	-	EPHB4 HECTD3 DDR2 AEBP1 SUCO	5.09e-04	73	168	5	2.60.120.260
Domain	EXOC3/Sec6	EXOC3L1 TNFAIP2	7.90e-04	5	168	2	IPR010326
Domain	Protocadherin	PCDH11X PCDH9	7.90e-04	5	168	2	PF08374
Domain	P-type_TPase_V	ATP13A4 ATP13A2	7.90e-04	5	168	2	IPR006544
Domain	Autophagy-rel_C	ATG2B VPS13B	7.90e-04	5	168	2	IPR015412
Domain	ATG_C	ATG2B VPS13B	7.90e-04	5	168	2	PF09333
Domain	Sec6	EXOC3L1 TNFAIP2	7.90e-04	5	168	2	PF06046
Domain	GATase	CAD CTPS2	7.90e-04	5	168	2	PF00117
Domain	Protocadherin	PCDH11X PCDH9	7.90e-04	5	168	2	IPR013585
Domain	EPTP	TSPEAR LGI1	1.18e-03	6	168	2	PF03736
Domain	MSP_dom	MOSPD3 CFAP65	1.18e-03	6	168	2	IPR000535
Domain	GATASE_TYPE_1	CAD CTPS2	1.18e-03	6	168	2	PS51273
Domain	EPTP	TSPEAR LGI1	1.18e-03	6	168	2	IPR005492
Domain	GATASE	CAD CTPS2	1.18e-03	6	168	2	IPR017926
Domain	MSP	MOSPD3 CFAP65	1.18e-03	6	168	2	PS50202
Domain	EAR	TSPEAR LGI1	1.64e-03	7	168	2	IPR009039
Domain	EAR	TSPEAR LGI1	1.64e-03	7	168	2	PS50912
Domain	PAP_assoc	TUT4 TUT1	1.64e-03	7	168	2	PF03828
Domain	PAP_assoc	TUT4 TUT1	1.64e-03	7	168	2	IPR002058
Domain	HECT	HECTD3 HUWE1 UBE3C	1.78e-03	27	168	3	PF00632
Domain	HECTc	HECTD3 HUWE1 UBE3C	1.78e-03	27	168	3	SM00119
Domain	HECT_dom	HECTD3 HUWE1 UBE3C	1.78e-03	27	168	3	IPR000569
Domain	HECT	HECTD3 HUWE1 UBE3C	1.78e-03	27	168	3	PS50237
Domain	Chorein_N	ATG2B VPS13B	2.17e-03	8	168	2	PF12624
Domain	VPS13_N	ATG2B VPS13B	2.17e-03	8	168	2	IPR026854
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPHB4 TRPM4 PDE2A CTC1 OBSCN ZDHHC5 AKNA SPIRE1 HUWE1 TTC3 DCTN1 TRRAP ATP13A2 MADD SLC7A1 TLK1 NPRL3 MAP3K11 MICAL3 TNFAIP2 UBE3C PLEC FUT1 WNK2	2.15e-09	1105	176	24	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPP2 PDE2A KIF23 CAD NRCAM GIT1 HUWE1 TEX10 TTC3 DCTN1 PBRM1 DCHS1 PPP1R3F APPL1 SCRIB UNC79 WNK2 DNMT1 LGI1	4.96e-07	963	176	19	28671696
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	EPHB4 CAD HECTD3 ZDHHC5 OBSL1 EPB41L5 DNAJC22 RRBP1 TTC3 DCTN1 SLC3A2 NEO1 OXA1L LRRC1 COL14A1 SCRIB ASCC3 MRPL49 ZNHIT2 SUCO RPL4 VPS13B AQR DNMT1	5.50e-07	1487	176	24	33957083
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PDE2A LARP6 B4GAT1 NRCAM GIT1 OBSL1 ADAMTS8 HUWE1 RAD54L2 RRBP1 TTC3 DCTN1 TXNDC11 MADD THBS1 MAP3K11 APPL1 ASTN2 SCRIB PLEC DNMT1 LGI1	6.47e-07	1285	176	22	35914814
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	NRCAM ICAM3 CDHR5 APOB LRG1 SLC3A2 THBS1 NEO1 FAT2 CDH6	8.44e-07	257	176	10	16335952
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	OBSCN EPB41L5 ZDBF2 HUWE1 PRX TRPM3 ROBO2	8.69e-07	101	176	7	10997877
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TRPM4 ZDHHC5 EPB41L5 CDHR5 APOB SLC3A2 SLC7A1 NEO1 PCDH11X MICAL3 SCRIB SLITRK6 PLEKHA7 VPS13B	1.38e-06	569	176	14	30639242
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ZDHHC5 EPB41L5 CBLB SLC3A2 CTPS2 DENND4B LRRC1 ROBO2 APPL1 MICAL3 SCRIB PLEKHA7	1.79e-06	421	176	12	36976175
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGA1 PCDHAC1 CDHR5 PCDH20 PCDH11X PCDH9	2.15e-06	74	176	6	10817752
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	HUWE1 TRRAP SLC3A2 CTPS2 PLEC RPL4	2.51e-06	76	176	6	27542412
Pubmed	Genetic mapping of mouse tumor necrosis factor-alpha converting enzyme (TACE) to chromosome 12.	NRCAM APOB ADAM17	2.52e-06	6	176	3	9598327
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGA1 PCDHAC1 PCDH20 FAT2 PCDH11X PCDH9	2.71e-06	77	176	6	10835267
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	KIF23 CAD GIT1 HUWE1 RRBP1 TEX10 TRRAP PBRM1 PHF3 SCRIB ASCC3 AQR	2.81e-06	440	176	12	34244565
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	AKNA PDZD7 DNAH7 RGS3 PHF3 PCDH11X PPP1R3F TET3 WNK2	3.21e-06	233	176	9	37704626
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGA1 PCDHAC1 PCDH20 FAT2 PCDH11X PCDH9	3.40e-06	80	176	6	10716726
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	KIF23 CTC1 DCLRE1B RAD54L2 TEX10 RFX1 SLC3A2 TLK1 TRMT2A PHF3 SHLD3 PRAME	3.79e-06	453	176	12	29656893
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KIF23 CAD CCDC22 ATG2B HUWE1 RFX1 DCTN1 TRRAP SLC3A2 PHF3 SCRIB ASCC3 DNMT1	5.01e-06	549	176	13	38280479
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPP2 KIF23 CAD DHX37 HUWE1 TEX10 TRRAP PBRM1 PHF3 PLEC ASCC3 RPL4 AQR DNMT1	6.69e-06	653	176	14	22586326
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NRCAM OBSL1 MADD PHF3 DENND4B MICAL3 SCRIB UBE3C TET3 VPS13B AQR	8.03e-06	407	176	11	12693553
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	CAD DHX37 ZDBF2 HUWE1 RAD54L2 RFX1 SLC3A2 ZSCAN29 MLXIPL TRMT2A PHF3 SCRIB RPL4	9.52e-06	583	176	13	29844126
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	TRIM72 KIF23 CAD ZDBF2 TRRAP RGS3 PBRM1 PLEC KIAA2012	1.12e-05	272	176	9	31010829
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IGSF8 TPP2 HDAC11 PDE2A CAD NRCAM GIT1 SPIRE1 RRBP1 DCTN1 MADD SLC3A2 MLXIPL C1QC MICAL3 SCRIB PLEC PLEKHA7 RPL4 WNK2 LGI1	1.27e-05	1431	176	21	37142655
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL20A1 APOB ADAMTS8 THBS1 COL14A1	1.88e-05	64	176	5	22261194
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	KIF23 TUT4 CCDC22 ATP7B EPB41L5 ZDBF2 HUWE1 RRBP1 MADD SLC3A2 NEO1 PHF3 UBE3C DNMT1	2.42e-05	733	176	14	34672954
Pubmed	Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.	APOB LPA	2.55e-05	2	176	2	24859635
Pubmed	OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.	APOB LPA	2.55e-05	2	176	2	21404224
Pubmed	Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.	SLC7A1 NOS3	2.55e-05	2	176	2	15743275
Pubmed	Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).	APOB LPA	2.55e-05	2	176	2	26975530
Pubmed	Ubiquitin ligase Cbl-b acts as a negative regulator in discoidin domain receptor 2 signaling via modulation of its stability.	DDR2 CBLB	2.55e-05	2	176	2	24631539
Pubmed	Eph-B4 mediates vein graft adaptation by regulation of endothelial nitric oxide synthase.	EPHB4 NOS3	2.55e-05	2	176	2	26817610
Pubmed	Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice.	PDE2A NOS3	2.55e-05	2	176	2	18849438
Pubmed	The Tumor Suppressor SCRIB is a Negative Modulator of the Wnt/β-Catenin Signaling Pathway.	LRRC1 SCRIB	2.55e-05	2	176	2	31513346
Pubmed	Lipoprotein (a): impact by ethnicity and environmental and medical conditions.	APOB LPA	2.55e-05	2	176	2	26637279
Pubmed	The kinase activation loop is the key to mixed lineage kinase-3 activation via both autophosphorylation and hematopoietic progenitor kinase 1 phosphorylation.	MAP4K1 MAP3K11	2.55e-05	2	176	2	11053428
Pubmed	Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.	APOB LPA	2.55e-05	2	176	2	26515419
Pubmed	MICAL3 Flavoprotein Monooxygenase Forms a Complex with Centralspindlin and Regulates Cytokinesis.	KIF23 MICAL3	2.55e-05	2	176	2	27528609
Pubmed	Role of DNA methyltransferase 1 on the altered eNOS expression in human umbilical endothelium from intrauterine growth restricted fetuses.	NOS3 DNMT1	2.55e-05	2	176	2	23867713
Pubmed	Associations of ChREBP and Global DNA Methylation with Genetic and Environmental Factors in Chinese Healthy Adults.	MLXIPL DNMT1	2.55e-05	2	176	2	27281235
Pubmed	Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells.	APOB LPA	2.55e-05	2	176	2	9548923
Pubmed	Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.	APOB LPA	2.55e-05	2	176	2	25614280
Pubmed	Polarity protein SCRIB interacts with SLC3A2 to regulate proliferation and tamoxifen resistance in ER+ breast cancer.	SLC3A2 SCRIB	2.55e-05	2	176	2	35501367
Pubmed	MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase.	MADD TNFRSF1A	2.55e-05	2	176	2	9115275
Pubmed	Sleep Duration, Lipid Profile and Insulin Resistance: Potential Role of Lipoprotein(a).	APOB LPA	2.55e-05	2	176	2	32630105
Pubmed	Mouse p150Glued (dynactin 1) cDNA sequence and evaluation as a candidate for the neuromuscular disease mutation mnd2.	HTRA2 DCTN1	2.55e-05	2	176	2	9070275
Pubmed	Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion.	APOB LPA	2.55e-05	2	176	2	35045727
Pubmed	High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.	APOB LPA	2.55e-05	2	176	2	15654123
Pubmed	Metrological traceability in mass spectrometry-based targeted protein quantitation: a proof-of-principle study for serum apolipoproteins A-I and B100.	APOB LPA	2.55e-05	2	176	2	24972322
Pubmed	The Suggestive Effect of Apo A, Apo B, and Apo A/Apo B on Erectile Dysfunction.	APOB LPA	2.55e-05	2	176	2	33423974
Pubmed	Reduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis.	ADAM17 TNFRSF1A	2.55e-05	2	176	2	18167350
Pubmed	Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk Assessment.	APOB LPA	2.55e-05	2	176	2	34461734
Pubmed	Roles for ADAM17 in TNF-R1 Mediated Cell Death and Survival in Human U937 and Jurkat Cells.	ADAM17 TNFRSF1A	2.55e-05	2	176	2	34831323
Pubmed	Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non-Small Cell Lung Cancer: Double-Edged Sword of DDR2.	DDR2 CBLB	2.55e-05	2	176	2	26826182
Pubmed	Splenocytes with fucosylation deficiency promote T cell proliferation and differentiation through thrombospondin-1 downregulation.	THBS1 FUT1	2.55e-05	2	176	2	37957948
Pubmed	Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma.	ATAT1 TEX10 CBLB	2.71e-05	12	176	3	12880961
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	TPP2 TUT4 CAD TRRAP PBRM1 PLEC RPL4 WNK2	2.83e-05	235	176	8	30258100
Pubmed	HIV-host interactome revealed directly from infected cells.	CAD ICAM3 HUWE1 AHR ITPRIP ADAM17 IL9R	2.92e-05	172	176	7	27375898
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	HECTD3 DHX37 OBSL1 RAD54L2 RRBP1 RGS3 MADD TRMT2A MICAL3 TNFAIP2 SCRIB AQR DNMT1	2.96e-05	650	176	13	38777146
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF23 GIT1 EPB41L5 SPIRE1 ATAT1 DNAH7 MADD MLXIPL PHF3 MAP4K1 SCRIB PLEC PLEKHA7 AQR DNMT1	3.54e-05	861	176	15	36931259
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CTC1 ESRP1 OBSCN SPIRE1 APOB HUWE1 TTC3 DCTN1 MADD SLC7A1 ITPRIP EXOC3L1 ADAM17 PLEC PLEKHA7 SUCO VPS13B	3.96e-05	1084	176	17	11544199
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	CAD CTC1 DHX37 EPB41L5 HUWE1 RRBP1 PBRM1 UBE3C ASCC3 RPL4 DNMT1	4.10e-05	486	176	11	30940648
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KIF23 GIT1 HUWE1 RRBP1 RFX1 TRRAP TLK1 PHF3 MAP4K1 APPL1 MICAL3 SCRIB PLEC DNMT1	4.36e-05	774	176	14	15302935
Pubmed	Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse.	PCDH11X CDH6 PCDH9	4.45e-05	14	176	3	20847152
Pubmed	The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.	HTRA2 RIOX1 HUWE1 RRBP1 TEX10 SLC3A2 PBRM1 RPL4	4.77e-05	253	176	8	29911972
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	KIF23 CAD OBSL1 APOB HUWE1 CBLB SLC3A2 OXA1L TTLL6 LRRC1 PLEC	4.92e-05	496	176	11	31343991
Pubmed	The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.	NPHS1 EPB41L5 SCRIB	5.54e-05	15	176	3	28536193
Pubmed	Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.	IGSF8 SLC3A2 SLC7A1 NEO1 TNFRSF1A PCDH9	5.96e-05	132	176	6	26439863
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	KIF23 CAD CCDC22 DHX37 EPB41L5 OAS3 HUWE1 RRBP1 TEX10 DCTN1 TRRAP SLC3A2 SCRIB PLEC ASCC3 MRPL49 RPL4 AQR DNMT1	6.08e-05	1353	176	19	29467282
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRPM4 TUT4 OBSCN SPIRE1 HUWE1 RRBP1 ATAT1 TTC3 TRRAP SLC7A1 TLK1 LRRC1 ASTN2 IGSF9 MICAL3 UBE3C TET3 VPS13B WNK2 CDH15	7.10e-05	1489	176	20	28611215
Pubmed	Genetic heterogeneity of plasma lipoproteins in the mouse: control of low density lipoprotein particle sizes by genetic factors.	APOB AHR	7.61e-05	3	176	2	1971301
Pubmed	Mammalian Scribble forms a tight complex with the betaPIX exchange factor.	GIT1 SCRIB	7.61e-05	3	176	2	15182672
Pubmed	EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.	EPHB4 APOB	7.61e-05	3	176	2	29643120
Pubmed	Assignment of a gene encoding ornithine decarboxylase to the proximal region of chromosome 12 in the mouse.	APOB AHR	7.61e-05	3	176	2	2627199
Pubmed	Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor.	PDE2A AHR	7.61e-05	3	176	2	17329248
Pubmed	Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages.	ADAM17 TNFRSF1A	7.61e-05	3	176	2	17510296
Pubmed	Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J.	APOB ADAM17	7.61e-05	3	176	2	10393218
Pubmed	HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway.	MAP4K1 MAP3K11	7.61e-05	3	176	2	9003777
Pubmed	Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma.	GIT1 SCRIB	7.61e-05	3	176	2	19041750
Pubmed	Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration.	THBS1 NOS3	7.61e-05	3	176	2	16311602
Pubmed	Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex.	OBSCN OBSL1	7.61e-05	3	176	2	20133654
Pubmed	Glyphosate and AMPA Induce Alterations in Expression of Genes Involved in Chromatin Architecture in Human Peripheral Blood Mononuclear Cells (In Vitro).	TET3 DNMT1	7.61e-05	3	176	2	33803994
Pubmed	Prostaglandin I2 Receptor Agonism Preserves β-Cell Function and Attenuates Albuminuria Through Nephrin-Dependent Mechanisms.	NPHS1 NOS3	7.61e-05	3	176	2	26868296
Pubmed	Candidate Oncogenes, ARHGAP4, NOS3, and OR51B5, for the Development of Scirrhous-type Gastric Cancer.	ARHGAP4 NOS3	7.61e-05	3	176	2	36288877
Pubmed	Neogenin pathway positively regulates fibronectin production by glomerular mesangial cells.	NEO1 NOS3	7.61e-05	3	176	2	35704698
Pubmed	Cadherin expression in the somatosensory cortex: evidence for a combinatorial molecular code at the single-cell level.	PCDH11X PCDH9	7.61e-05	3	176	2	21129452
Pubmed	Binding of Myomesin to Obscurin-Like-1 at the Muscle M-Band Provides a Strategy for Isoform-Specific Mechanical Protection.	OBSCN OBSL1	7.61e-05	3	176	2	27989621
Pubmed	Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.	APOB LPA	7.61e-05	3	176	2	23701995
Pubmed	Ultraviolet B inhibition of DNMT1 activity via AhR activation dependent SIRT1 suppression in CD4+ T cells from systemic lupus erythematosus patients.	AHR DNMT1	7.61e-05	3	176	2	28336124
Pubmed	Lifestyle and socioeconomic-status modify the effects of ADRB2 and NOS3 on adiposity in European-American and African-American adolescents.	APOB NOS3	7.61e-05	3	176	2	20930716
Pubmed	Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in Mice.	ADAM17 TNFRSF1A	7.61e-05	3	176	2	28062509
Pubmed	Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).	APOB LPA	7.61e-05	3	176	2	23973688
Pubmed	GTP cyclohydrolase I/BH4 pathway protects EPCs via suppressing oxidative stress and thrombospondin-1 in salt-sensitive hypertension.	THBS1 NOS3	7.61e-05	3	176	2	21059996
Pubmed	Murine obscurin and Obsl1 have functionally redundant roles in sarcolemmal integrity, sarcoplasmic reticulum organization, and muscle metabolism.	OBSCN OBSL1	7.61e-05	3	176	2	31098411
Pubmed	The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.	APOB LPA	7.61e-05	3	176	2	22407494
Pubmed	Cbl negatively regulates JNK activation and cell death.	CBLB MAP3K11	7.61e-05	3	176	2	19546888
Pubmed	A role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) α-converting enzyme (TACE/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes.	ADAM17 TNFRSF1A	7.61e-05	3	176	2	22898814
Pubmed	LAP proteins are localized at the post-synaptic membrane of neuromuscular junctions and appear to modulate synaptic morphology and transmission.	LRRC1 SCRIB	7.61e-05	3	176	2	27321929
Pubmed	Role of the polarity protein Scribble for podocyte differentiation and maintenance.	NPHS1 SCRIB	7.61e-05	3	176	2	22586490
Pubmed	Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin.	OBSCN OBSL1	7.61e-05	3	176	2	20489725
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	CAD RRBP1 THBS1 PLEC ASCC3 RPL4 DNMT1	8.08e-05	202	176	7	33005030
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	CAD RRBP1 DCTN1 SLC3A2 SCRIB ASCC3 AQR	8.08e-05	202	176	7	24639526
GeneFamily	Fibronectin type III domain containing	EPHB4 NPHS1 IGFN1 NRCAM COL20A1 OBSCN FNDC4 NEO1 LRRN4CL LRFN5 ROBO2 ASTN2 IGSF9 COL14A1	1.48e-12	160	114	14	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGFN1 NRCAM OBSCN OBSL1 NEO1 HMCN2 LRFN5 ROBO2 IGSF9	8.21e-07	161	114	9	593
GeneFamily	Immunoglobulin like domain containing	NPHS1 NRCAM ICAM3 OBSL1 FCRLA NEO1 HMCN2 IGSF9	3.06e-05	193	114	8	594
GeneFamily	Non-clustered protocadherins	PCDH20 PCDH11X PCDH9	5.15e-05	12	114	3	21
GeneFamily	Cadherin related	CDHR5 FAT2 DCHS1	1.56e-04	17	114	3	24
GeneFamily	Parkinson disease associated genes\|ATPase orphan transporters	ATP13A4 ATP13A2	3.89e-04	5	114	2	1213
GeneFamily	Non-canonical poly(A) polymerases	TUT4 TUT1	8.11e-04	7	114	2	1318
GeneFamily	Zinc fingers CXXC-type	TET3 DNMT1	2.50e-03	12	114	2	136
GeneFamily	PDZ domain containing	HTRA2 PDZD7 RGS3 PRX SCRIB	2.77e-03	152	114	5	1220
GeneFamily	Parkinson disease associated genes	HTRA2 ATP13A2	4.46e-03	16	114	2	672
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	EPHB4 CAD ATP7B B4GAT1 OBSL1 RRBP1 ARHGAP4 ADAM17 TNFAIP2 PLEC PRAME AQR	3.74e-07	276	175	12	M3063
Coexpression	GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN	NRCAM BACH2 ESRP1 CBLB SLC3A2 THBS1 NEO1 SRL NOS3	1.59e-06	163	175	9	M6722
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	KIF23 TUT4 SLC7A1 TLK1 FAT2 PHF3 SUCO VPS13B	6.16e-06	145	175	8	M1810
ToppCell	Pericytes-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	SGCA BACH2 CPA1 ADAMTS8 DNAJC22 KCNA5 AEBP1 SRL COL14A1 CDH6	4.03e-09	187	176	10	35f25780d113f60bf4c13749013c09612ee4ff41
ToppCell	ASK428-Mesenchymal\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	LARP6 SGCA DDR2 ADAMTS8 THBS1 AEBP1 ROBO2 COL14A1 CDH6 PRDM6	6.03e-09	195	176	10	2b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCell	ASK428-Mesenchymal-Fibroblast\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	LARP6 SGCA DDR2 ADAMTS8 THBS1 AEBP1 ROBO2 COL14A1 CDH6 PRDM6	6.03e-09	195	176	10	c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BACH2 DDR2 ADAMTS8 CPED1 THBS1 AEBP1 LRFN5 ROBO2 COL14A1 PRDM6	7.68e-09	200	176	10	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Pericytes-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	NRCAM SGCA DDR2 DNAJC22 HMCN2 AEBP1 LRFN5 COL14A1 CDH6	4.61e-08	181	176	9	35c470988a93381eefa300831aabb813fa1b90bd
ToppCell	(07)_Brush\|World / shred by cell type and Timepoint	IGSF8 EPHB4 PDE2A NRCAM PCDH20 ARHGAP4 ROBO2 SLITRK6 WNK2	7.99e-08	193	176	9	9af9d22a130ff97a9c37142a65e841b056d08640
ToppCell	distal-mesenchymal-Airway_Smooth_Muscle-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SGCA CPA1 ADAMTS8 KCNA5 AEBP1 SRL COL14A1 CDH6 PRDM6	1.08e-07	200	176	9	bc969a956f62570419a5faaf0ab0fd17b343c5ca
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BACH2 DDR2 ADAMTS8 THBS1 AEBP1 LRFN5 ROBO2 COL14A1 PRDM6	1.08e-07	200	176	9	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Pericytes-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	SGCA DDR2 CPA1 ADAMTS8 CC2D2B KCNA5 SRL COL14A1	4.98e-07	175	176	8	ddf721023a7afc8085c5de17aa254a6575444c0f
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	SGCA DDR2 ADAMTS8 CPED1 KCNA5 AEBP1 COL14A1 CDH6	4.98e-07	175	176	8	fed9e4120c758fdcc23bb248d1801002b0e0d485
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC2A9 NRCAM DNAH7 MLXIPL TRPM3 ASTN2 PLEKHA7 CDH6	6.98e-07	183	176	8	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 IGFN1 NRCAM OBSCN APOB TRPM3 PCDH11X UNC79	7.27e-07	184	176	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 IGFN1 NRCAM OBSCN APOB TRPM3 PCDH11X UNC79	7.27e-07	184	176	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 IGFN1 NRCAM OBSCN APOB TRPM3 PCDH11X UNC79	7.27e-07	184	176	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA DDR2 ADAMTS8 THBS1 AEBP1 ROBO2 COL14A1 PRDM6	7.89e-07	186	176	8	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 ADAMTS8 THBS1 AEBP1 ASTN2 COL14A1 PRDM6	8.90e-07	189	176	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRCAM BACH2 ADAMTS8 CBLB THBS1 LRFN5 ROBO2 TNFAIP2	9.63e-07	191	176	8	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 ADAMTS8 CPED1 THBS1 AEBP1 COL14A1 PRDM6	1.00e-06	192	176	8	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 ADAMTS8 CPED1 THBS1 AEBP1 COL14A1 PRDM6	1.00e-06	192	176	8	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 ADAMTS8 CPED1 THBS1 AEBP1 COL14A1 PRDM6	1.00e-06	192	176	8	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	SGCA ADAMTS8 CPED1 KCNA5 AEBP1 SRL COL14A1 CDH6	1.04e-06	193	176	8	9104b572d9c3c99080e4b7455993fbb944bf117d
ToppCell	tumor_Lung-Fibroblasts-Smooth_muscle_cells\|tumor_Lung / Location, Cell class and cell subclass	SGCA ADAMTS8 CPED1 KCNA5 AEBP1 ROBO2 CDH6 PRDM6	1.13e-06	195	176	8	ea9ff25020c2fcd1bab80e1829af0f4e4777de8b
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	NRCAM DDR2 THBS1 AEBP1 LRFN5 ROBO2 COL14A1 PRDM6	1.26e-06	198	176	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)\|390C / Donor, Lineage, Cell class and subclass (all cells)	SGCA FNDC4 ADAMTS8 CPED1 THBS1 KCNA5 AEBP1 CDH6	1.26e-06	198	176	8	c82a151f9f1477d4a401457173b8d72af776c137
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	SGCA FNDC4 ADAMTS8 CPED1 THBS1 KCNA5 AEBP1 CDH6	1.26e-06	198	176	8	dc63b56bb6291e527b172d603569376286262845
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRCAM DDR2 THBS1 AEBP1 LRFN5 ROBO2 COL14A1 PRDM6	1.26e-06	198	176	8	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM SGCA CPED1 RGS3 KCNA5 CDH6 PCDH9 PRDM6	1.26e-06	198	176	8	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SGCA ADAMTS8 THBS1 KCNA5 AEBP1 SRL COL14A1 CDH6	1.31e-06	199	176	8	0a145172787f40d0fdaf21188d539ffaf7ece3e4
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SGCA ADAMTS8 CPED1 THBS1 KCNA5 AEBP1 COL14A1 CDH6	1.31e-06	199	176	8	8ff0fdcbe9661b013913731ec8b53d84836ca865
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SGCA ADAMTS8 THBS1 KCNA5 AEBP1 SRL COL14A1 CDH6	1.31e-06	199	176	8	c2903b1a4b91e94bbdaa909bacefe901255cf248
ToppCell	proximal-mesenchymal-Airway_Smooth_Muscle-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SGCA ADAMTS8 CPED1 KCNA5 AEBP1 SRL COL14A1 CDH6	1.36e-06	200	176	8	6fa339666c4032b29ac521e88f0e917a57013cde
ToppCell	proximal-3-mesenchymal-Airway_Smooth_Muscle\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SGCA ADAMTS8 CPED1 KCNA5 AEBP1 SRL COL14A1 CDH6	1.36e-06	200	176	8	e9a008bfe336002218c63d1c2231986e1b237621
ToppCell	proximal-mesenchymal-Airway_Smooth_Muscle\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SGCA ADAMTS8 CPED1 KCNA5 AEBP1 SRL COL14A1 CDH6	1.36e-06	200	176	8	5eeb8eb3fe74f5a8055c52ec77e38237bb63ed90
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	NRCAM BACH2 AEBP1 ROBO2 EXOC3L1 SLITRK6 PRDM6	3.23e-06	158	176	7	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRIM72 SGCA DDR2 ADAMTS8 KCNA5 TRPM3 SRL	3.81e-06	162	176	7	5d902bb31e691aea9749617cc88303c2448f24b8
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRIM72 SGCA DDR2 ADAMTS8 KCNA5 TRPM3 SRL	3.81e-06	162	176	7	c7114e24cb5525abb9780ca3d35dbcc4eabd4b64
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRIM72 SGCA DDR2 ADAMTS8 KCNA5 TRPM3 SRL	3.81e-06	162	176	7	f1851a173d3bcca2981d934161ec85d1cc0af5a2
ToppCell	facs-Marrow-B-cells-24m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RRBP1 CPED1 PCDH20 TXNDC11 SLC3A2 MLXIPL FUT1	5.65e-06	172	176	7	a7fd4d61fb5017dce001d69d6b9a01e6cdf58828
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SGCA DDR2 DNAJC22 AEBP1 ROBO2 COL14A1 PRDM6	5.86e-06	173	176	7	26e2e674f5d312fa8f61c11b553dc6101f063b16
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	SGCA DDR2 DNAJC22 AEBP1 ROBO2 COL14A1 PRDM6	5.86e-06	173	176	7	75e26a65071b0d2f30ed0b2aa9859c488f5cf362
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	EPHB4 GIT1 RGS3 PRX CFAP65 LRRN4CL AHR	6.09e-06	174	176	7	b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRCAM BACH2 ADAMTS8 ROBO2 SLITRK6 CDH6 PRDM6	6.81e-06	177	176	7	b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCell	Pericytes-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	SGCA DDR2 ADAMTS8 KCNA5 AEBP1 COL14A1 CDH6	7.07e-06	178	176	7	a2448d868da2abe48c394c51264aad03e866dfec
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FMO5 SLC2A9 CDHR5 ABCC6 MLXIPL TRPM3 CDH6	7.33e-06	179	176	7	d1ef7e1cb00336118e387b47f4f8120f53584391
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 CPED1 ASTN2 COL14A1 MICAL3 PRDM6	7.60e-06	180	176	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	NPHS1 DDR2 CPA1 LRRN4CL TRPM3 COL14A1 CDH15	8.17e-06	182	176	7	354dcdb01360597f68c4fe157a682aee1c0b8bb1
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	IGFN1 NRCAM SGCA DDR2 KCNA5 SRL COL14A1	8.47e-06	183	176	7	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	Pericytes-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	SGCA KCNA5 AEBP1 DCHS1 SRL COL14A1 CDH6	8.77e-06	184	176	7	cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA CPA1 KCNA5 AEBP1 COL14A1 CDH6 PRDM6	8.77e-06	184	176	7	603faafb7b289a3c0242c84fc800c050c8a092ea
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA CPA1 KCNA5 AEBP1 COL14A1 CDH6 PRDM6	8.77e-06	184	176	7	c350504bfe0ec31cd2fc2199de9b5fff151a8c5e
ToppCell	droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSL1 FCRLA RRBP1 ATAT1 CPED1 TXNDC11 FUT1	9.09e-06	185	176	7	e583f6601f9ed79b0b23d2f9426a4ba8b969230b
ToppCell	(7)_MNP-(7)_DC_plasmacytoid\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	FCRLA RRBP1 ATP13A2 SLC3A2 KCNA5 SLC12A3 AEBP1	9.09e-06	185	176	7	9f67f652488e17075a372e2a2e1100f6d0af6d7d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	IGFN1 ADAMTS8 THBS1 AEBP1 LRFN5 ROBO2 PRDM6	9.75e-06	187	176	7	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRCAM BACH2 CPED1 AEBP1 ROBO2 SLITRK6 PRDM6	9.75e-06	187	176	7	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC2A9 CDHR5 ABCC6 MLXIPL TRPM3 PLEKHA7 CDH6	1.01e-05	188	176	7	f3edcefeef2ce19086032d98b243c02a6d542b38
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC2A9 CDHR5 ABCC6 MLXIPL TRPM3 PLEKHA7 CDH6	1.01e-05	188	176	7	0792432cd4c564dea1102241ea9884f7ced7658c
ToppCell	Pericytes-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	LARP6 SGCA CPED1 KCNA5 AEBP1 COL14A1 CDH6	1.01e-05	188	176	7	14c1c88a944c66f2eaac1ce7526815dcce1f5147
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR2 RRBP1 THBS1 LRRN4CL AEBP1 COL14A1 TNFAIP2	1.08e-05	190	176	7	d13fd234caa3fc69d8a59bc0060cdacdf716ee55
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 ADAMTS8 THBS1 AEBP1 COL14A1 PRDM6	1.12e-05	191	176	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC2A9 ABCC6 MLXIPL TRPM3 MICAL3 PLEKHA7 CDH6	1.12e-05	191	176	7	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DDR2 ADAMTS8 AEBP1 ROBO2 ASTN2 COL14A1 PRDM6	1.12e-05	191	176	7	cd497abed9e00e4e0becd9dbc036c6e7a60ae791
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC2A9 ABCC6 MLXIPL TRPM3 MICAL3 PLEKHA7 CDH6	1.12e-05	191	176	7	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	COVID-19-kidney-vSMC/Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	SGCA DDR2 CPED1 THBS1 KCNA5 AEBP1 SRL	1.12e-05	191	176	7	fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDR2 CPED1 AEBP1 ASTN2 COL14A1 CDH6 PRDM6	1.12e-05	191	176	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 ADAMTS8 THBS1 AEBP1 COL14A1 PRDM6	1.16e-05	192	176	7	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	Pericytes\|World / lung cells shred on cell class, cell subclass, sample id	SGCA DDR2 KCNA5 AEBP1 SRL COL14A1 CDH6	1.16e-05	192	176	7	057ad22b878c0c5fb59ed1412ca13db945c57a5a
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA FNDC4 THBS1 LRRN4CL AEBP1 COL14A1 PRDM6	1.20e-05	193	176	7	5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0
ToppCell	ILEUM-inflamed-(8)_Smooth_muscle_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SGCA DDR2 ADAMTS8 CPED1 AEBP1 CDH6 PRDM6	1.20e-05	193	176	7	084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 ADAMTS8 CPED1 ASTN2 COL14A1 PRDM6	1.20e-05	193	176	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LARP6 NRCAM PKDREJ NEO1 AEBP1 PCDH11X PRDM6	1.24e-05	194	176	7	7826fe5eb254ac032de0d978f39585a40e0b3ee4
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDR2 ADAMTS8 CPED1 THBS1 AEBP1 COL14A1 PRDM6	1.24e-05	194	176	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM DDR2 ADAMTS8 THBS1 LRFN5 COL14A1 PRDM6	1.24e-05	194	176	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA CPED1 KCNA5 AEBP1 COL14A1 CDH6 PRDM6	1.28e-05	195	176	7	a52ee3ad6cd317f10b9308450517861ef2e363bb
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)\|356C / Donor, Lineage, Cell class and subclass (all cells)	SGCA ADAMTS8 KCNA5 AEBP1 COL14A1 CDH6 PRDM6	1.32e-05	196	176	7	a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DDR2 CPED1 HMCN2 AEBP1 COL14A1 PRDM6 WNK2	1.32e-05	196	176	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA FNDC4 ADAMTS8 CPED1 AEBP1 COL14A1 CDH6	1.32e-05	196	176	7	f78951b460913866d092ba92af70ea76a2afa73e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA ADAMTS8 CPED1 KCNA5 AEBP1 COL14A1 CDH6	1.32e-05	196	176	7	b55aa507429ddce89ad4f42ab6daeca2f34fd676
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SGCA ADAMTS8 KCNA5 AEBP1 COL14A1 CDH6 PRDM6	1.32e-05	196	176	7	476812fc1422aca8010d771eff11fa6081f15a2d
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DDR2 ADAMTS8 AEBP1 LRFN5 ROBO2 COL14A1 PRDM6	1.32e-05	196	176	7	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DDR2 CPED1 HMCN2 AEBP1 COL14A1 PRDM6 WNK2	1.32e-05	196	176	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA FNDC4 ADAMTS8 CPED1 AEBP1 COL14A1 CDH6	1.32e-05	196	176	7	4da96672a9c72268cfcc82d61eb3caae6e02d4c4
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA ADAMTS8 CPED1 KCNA5 AEBP1 COL14A1 CDH6	1.32e-05	196	176	7	cda3681f032f740cb09c64c62b9153cb62dbb5d2
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA FNDC4 ADAMTS8 CPED1 AEBP1 COL14A1 CDH6	1.32e-05	196	176	7	69ad90a429af4dad5a45556544224001ebcb1607
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA ADAMTS8 CPED1 KCNA5 AEBP1 COL14A1 CDH6	1.32e-05	196	176	7	208ddedd29e1b9ca89cbb9b527c2e193a44cada2
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NRCAM DDR2 ADAMTS8 RRBP1 THBS1 LRFN5 COL14A1	1.37e-05	197	176	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGCA DDR2 CPED1 KCNA5 AEBP1 SRL COL14A1	1.37e-05	197	176	7	02e70768a917c5f097bc653e9e965a1000289d2e
ToppCell	343B-Fibroblasts-Fibroblast-K_(Pericytes)\|343B / Donor, Lineage, Cell class and subclass (all cells)	SGCA CPED1 KCNA5 AEBP1 COL14A1 CDH6 PRDM6	1.37e-05	197	176	7	78d45d11820ec379942c4c3defd619d5f8cc8e1f
ToppCell	343B-Fibroblasts-Fibroblast-K_(Pericytes)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	SGCA CPED1 KCNA5 AEBP1 COL14A1 CDH6 PRDM6	1.37e-05	197	176	7	31bc9fd679d78550541d4158568e8dd09ff29e8e
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	NRCAM DDR2 THBS1 AEBP1 ROBO2 COL14A1 PRDM6	1.37e-05	197	176	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM DDR2 ADAMTS8 RRBP1 THBS1 ROBO2 PRDM6	1.41e-05	198	176	7	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	BACH2 DDR2 ADAMTS8 AEBP1 LRFN5 ROBO2 PRDM6	1.41e-05	198	176	7	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BACH2 DDR2 THBS1 LRFN5 ROBO2 COL14A1 PRDM6	1.41e-05	198	176	7	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 LRG1 KCNA5 AEBP1 COL14A1 MICAL3 CDH6	1.41e-05	198	176	7	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SGCA CPED1 KCNA5 AEBP1 COL14A1 CDH6 PRDM6	1.41e-05	198	176	7	c7075dce915ab8387309fcb12c5f6a17d4100cda
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NRCAM DDR2 ADAMTS8 CPED1 THBS1 COL14A1 SLITRK6	1.46e-05	199	176	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPED1 LRG1 KCNA5 AEBP1 COL14A1 MICAL3 CDH6	1.46e-05	199	176	7	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	BACH2 DDR2 AEBP1 LRFN5 ROBO2 COL14A1 PRDM6	1.46e-05	199	176	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGCA DDR2 ADAMTS8 LRRN4CL AEBP1 COL14A1 PRDM6	1.46e-05	199	176	7	0019cfaa586a450c2e4952d1184a540561c8d0ba
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DDR2 CPED1 AEBP1 LRFN5 ROBO2 COL14A1 PRDM6	1.51e-05	200	176	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DDR2 CPED1 AEBP1 LRFN5 PCDH11X COL14A1 PCDH9	1.51e-05	200	176	7	a4ec0e80f5422b91b85264a9bb74568dd577e285
Disease	Malignant neoplasm of breast	EPHB4 PDE2A MAN2C1 ATP7B B4GAT1 NRCAM OBSCN TTC3 PKDREJ PCDH20 THBS1 PBRM1 TRMT2A KCNA5 AHR APPL1 ASTN2 EXOC3L1 ZNHIT2 NOS3 VPS13B DNMT1	2.70e-07	1074	170	22	C0006142
Disease	Hyperoxia	AHR TNFRSF1A	9.86e-05	3	170	2	C0242706
Disease	total lipids in lipoprotein particles measurement	APOB MLXIPL LPA FUT1	1.70e-04	48	170	4	EFO_0022309
Disease	juvenile-onset Parkinson's disease (implicated_via_orthology)	ATP13A4 ATP13A2	1.96e-04	4	170	2	DOID:0060893 (implicated_via_orthology)
Disease	Kufor-Rakeb syndrome (implicated_via_orthology)	ATP13A4 ATP13A2	1.96e-04	4	170	2	DOID:0060556 (implicated_via_orthology)
Disease	triglycerides to total lipids in very large VLDL percentage	APOB MLXIPL LPA MAP3K11	2.50e-04	53	170	4	EFO_0022340
Disease	cholesterol to total lipids in very large VLDL percentage	APOB MLXIPL LPA MAP3K11	2.69e-04	54	170	4	EFO_0022244
Disease	cholesterol to total lipids in large HDL percentage	APOB MADD MLXIPL LPA	2.88e-04	55	170	4	EFO_0022234
Disease	corpus callosum volume measurement	ZDHHC5 ATP13A2 ENO4 PLEC WNK2	2.90e-04	100	170	5	EFO_0010299
Disease	Breast Carcinoma	EPHB4 PDE2A MAN2C1 ATP7B B4GAT1 NRCAM THBS1 PBRM1 AHR NOS3 DNMT1	3.05e-04	538	170	11	C0678222
Disease	irritable bowel syndrome (implicated_via_orthology)	MLXIPL NOS3	3.26e-04	5	170	2	DOID:9778 (implicated_via_orthology)
Disease	Dyslipidemias	ATP7B APOB AHR	3.48e-04	24	170	3	C0242339
Disease	Dyslipoproteinemias	ATP7B APOB AHR	3.48e-04	24	170	3	C0598784
Disease	brain measurement, neuroimaging measurement	ADAMTS8 CPED1 ATP13A2 THBS1 NEO1 PBRM1 KCNA5 ROBO2 IGSF9 PLEC WNK2	3.68e-04	550	170	11	EFO_0004346, EFO_0004464
Disease	free cholesterol to total lipids in very large VLDL percentage	APOB MLXIPL LPA MAP3K11	3.78e-04	59	170	4	EFO_0022289
Disease	triglycerides to total lipids in large HDL percentage	APOB MADD MLXIPL LPA	4.03e-04	60	170	4	EFO_0022330
Disease	free cholesterol to total lipids in medium HDL percentage	APOB MADD MLXIPL LPA	4.03e-04	60	170	4	EFO_0022282
Disease	brain connectivity measurement	ADAMTS8 CPED1 ENO4 THBS1 KCNA5 ROBO2 ASTN2 PLEC WNK2	5.48e-04	400	170	9	EFO_0005210
Disease	Autosomal Dominant Parkinsonism	HTRA2 DCTN1 ATP13A2	5.54e-04	28	170	3	C0752098
Disease	Autosomal Dominant Juvenile Parkinson Disease	HTRA2 DCTN1 ATP13A2	5.54e-04	28	170	3	C0752097
Disease	Parkinsonism, Experimental	HTRA2 DCTN1 ATP13A2	5.54e-04	28	170	3	C0752101
Disease	Autosomal Recessive Parkinsonism	HTRA2 DCTN1 ATP13A2	5.54e-04	28	170	3	C0752100
Disease	Familial Juvenile Parkinsonism	HTRA2 DCTN1 ATP13A2	5.54e-04	28	170	3	C0752104
Disease	Ramsay Hunt Paralysis Syndrome	HTRA2 DCTN1 ATP13A2	5.54e-04	28	170	3	C0242423
Disease	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	HTRA2 DCTN1 ATP13A2	5.54e-04	28	170	3	C1868675
Disease	total lipids in very large HDL measurement	APOB MADD MLXIPL LPA	5.80e-04	66	170	4	EFO_0022312
Disease	phospholipids in very large HDL measurement	APOB MADD MLXIPL LPA	5.80e-04	66	170	4	EFO_0022298
Disease	MASA syndrome (implicated_via_orthology)	NRCAM TRPM3	6.80e-04	7	170	2	DOID:0060246 (implicated_via_orthology)
Disease	Parkinsonism, Juvenile	HTRA2 DCTN1 ATP13A2	6.80e-04	30	170	3	C0752105
Disease	Parkinsonian Disorders	HTRA2 DCTN1 ATP13A2	6.80e-04	30	170	3	C0242422
Disease	cholesterol in very large HDL measurement	APOB MADD MLXIPL LPA	6.87e-04	69	170	4	EFO_0022229
Disease	cholesteryl esters to total lipids in large LDL percentage	APOB MLXIPL LPA	7.50e-04	31	170	3	EFO_0022249
Disease	total lipids in large HDL	APOB MADD MLXIPL LPA	8.94e-04	74	170	4	EFO_0022189
Disease	Autistic behavior	TRPM3 TET3	9.03e-04	8	170	2	C0856975
Disease	benign neoplasm (implicated_via_orthology)	LRRC1 SCRIB	9.03e-04	8	170	2	DOID:0060072 (implicated_via_orthology)
Disease	Mammary Carcinoma, Human	EPHB4 PDE2A MAN2C1 ATP7B B4GAT1 NRCAM THBS1 AHR NOS3 DNMT1	9.82e-04	525	170	10	C4704874
Disease	Mammary Neoplasms, Human	EPHB4 PDE2A MAN2C1 ATP7B B4GAT1 NRCAM THBS1 AHR NOS3 DNMT1	9.82e-04	525	170	10	C1257931
Disease	Mammary Neoplasms	EPHB4 PDE2A MAN2C1 ATP7B B4GAT1 NRCAM THBS1 AHR NOS3 DNMT1	1.01e-03	527	170	10	C1458155
Disease	free cholesterol in large HDL measurement	APOB MADD MLXIPL LPA	1.14e-03	79	170	4	EFO_0022157
Disease	Cardiovascular Diseases	APOB LPA NOS3	1.17e-03	36	170	3	C0007222
Disease	cholesterol in large HDL measurement	APOB MADD MLXIPL LPA	1.20e-03	80	170	4	EFO_0021900
Disease	cholesteryl esters to total lipids in medium LDL percentage	APOB MLXIPL LPA	1.26e-03	37	170	3	EFO_0022252
Disease	lung non-small cell carcinoma (is_implicated_in)	CBLB SLC3A2 PBRM1 TNFRSF1A DNMT1	1.29e-03	139	170	5	DOID:3908 (is_implicated_in)
Disease	body surface area	HDAC11 PDE2A CPED1 ATP13A2 SPATA31C1 NPRL3 ASTN2 SCRIB PLEC UNC79 DNMT1	1.32e-03	643	170	11	EFO_0022196
Disease	neuroimaging measurement	ZDHHC5 MFSD2B ATP13A2 ENO4 MLXIPL THBS1 NEO1 KCNA5 DENND4B MAP3K11 ROBO2 IGSF9 PLEC PLEKHA7 WNK2	1.38e-03	1069	170	15	EFO_0004346
Disease	level of Triacylglycerol (51:3) in blood serum	APOB MLXIPL	1.44e-03	10	170	2	OBA_2045163
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	APOB MLXIPL	1.75e-03	11	170	2	OBA_2045170
Disease	kidney cancer (implicated_via_orthology)	LRRC1 SCRIB	1.75e-03	11	170	2	DOID:263 (implicated_via_orthology)
Disease	Secondary Biliary Cholangitis	ICAM3 TNFRSF1A NOS3	1.83e-03	42	170	3	C0238065
Disease	Biliary cirrhosis	ICAM3 TNFRSF1A NOS3	1.83e-03	42	170	3	C0023892
Disease	Biliary Cirrhosis, Primary, 1	ICAM3 TNFRSF1A NOS3	1.83e-03	42	170	3	C4551595
Disease	cholesteryl esters to total lipids in small LDL percentage	APOB MLXIPL LPA	1.83e-03	42	170	3	EFO_0022255
Disease	cholesteryl esters to total lipids in small HDL percentage	APOB MLXIPL LPA	1.96e-03	43	170	3	EFO_0022254
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB MLXIPL LPA	1.96e-03	43	170	3	EFO_0022290
Disease	Cachexia	TNFRSF1A CDH6	2.10e-03	12	170	2	C0006625
Disease	transient cerebral ischemia (biomarker_via_orthology)	MADD ROBO2 TNFRSF1A NOS3 WNK2	2.21e-03	157	170	5	DOID:224 (biomarker_via_orthology)
Disease	saturated fatty acids measurement	APOB MLXIPL LPA	2.23e-03	45	170	3	EFO_0022304
Disease	cholesterol to total lipids in large VLDL percentage	APOB MLXIPL LPA	2.23e-03	45	170	3	EFO_0022236
Disease	mean reticulocyte volume	KIF23 CAD BACH2 MOSPD3 TRRAP CPED1 TXNDC11 MLXIPL NPRL3 SRL CDH6 CDH15	2.39e-03	799	170	12	EFO_0010701
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	OBSL1 APOB RRBP1 MADD MLXIPL SLC12A3 LPA	2.42e-03	315	170	7	EFO_0004612, EFO_0008591
Disease	cardiomyopathy (biomarker_via_orthology)	PDE2A NOS3	2.47e-03	13	170	2	DOID:0050700 (biomarker_via_orthology)
Disease	systemic lupus erythematosus (is_marker_for)	LPA TNFRSF1A DNMT1	2.53e-03	47	170	3	DOID:9074 (is_marker_for)
Disease	Primary biliary cirrhosis	ICAM3 TNFRSF1A NOS3	2.53e-03	47	170	3	C0008312
Disease	epilepsy (implicated_via_orthology)	NRCAM KCNA5 SLC12A3 NOS3 LGI1	2.59e-03	163	170	5	DOID:1826 (implicated_via_orthology)
Disease	Colorectal Carcinoma	CAD ATP7B NRCAM FPGS OBSCN TSPEAR APOB ABCC6 PCDH11X DCHS1 BPIFB2	2.61e-03	702	170	11	C0009402
Disease	Male sterility	ENO4 AHR NOS3	2.69e-03	48	170	3	C0917731
Disease	Male infertility	ENO4 AHR NOS3	2.69e-03	48	170	3	C0021364
Disease	Subfertility, Male	ENO4 AHR NOS3	2.69e-03	48	170	3	C0848676
Disease	cholesteryl esters to total lipids in small VLDL percentage	APOB MLXIPL LPA	2.85e-03	49	170	3	EFO_0022256
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	ATP13A4 ATP13A2	2.87e-03	14	170	2	DOID:14503 (implicated_via_orthology)
Disease	Autosomal recessive limb-girdle muscular dystrophy	SGCA PLEC	2.87e-03	14	170	2	cv:C2931907
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	APOB MADD MLXIPL SLC12A3 LPA CDH15	2.93e-03	243	170	6	EFO_0004612, EFO_0020944
Disease	triglycerides to total lipids in medium LDL percentage	APOB MLXIPL LPA	3.02e-03	50	170	3	EFO_0022334
Disease	polyunsaturated fatty acids to total fatty acids percentage	APOB MLXIPL LPA	3.02e-03	50	170	3	EFO_0022303
Disease	cholesteryl esters to total lipids in IDL percentage	APOB MLXIPL LPA	3.02e-03	50	170	3	EFO_0022247
Disease	response to cisplatin	BACH2 SLITRK6 PCDH9	3.19e-03	51	170	3	GO_0072718
Disease	triglycerides to total lipids in large LDL percentage	APOB MLXIPL LPA	3.19e-03	51	170	3	EFO_0022331
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	APOB MLXIPL LPA	3.19e-03	51	170	3	EFO_0022302
Disease	cholesterol to total lipids in small HDL percentage	APOB MLXIPL LPA	3.19e-03	51	170	3	EFO_0022240
Disease	cholesterol to total lipids in small VLDL percentage	MLXIPL LPA MAP3K11	3.19e-03	51	170	3	EFO_0022242
Disease	free cholesterol to total lipids in small HDL percentage	APOB MADD LPA	3.19e-03	51	170	3	EFO_0022285
Disease	triacylglycerol 52:3 measurement	APOB MLXIPL	3.30e-03	15	170	2	EFO_0010415
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	APOB LPA	3.30e-03	15	170	2	EFO_0022328
Disease	response to statin, LDL cholesterol change measurement	APOB LPA	3.30e-03	15	170	2	EFO_0007804, GO_0036273
Disease	obsolete aging, cognition	CBLB AHR	3.30e-03	15	170	2	EFO_0003925, GO_0007568
Disease	phospholipids in medium VLDL measurement	APOB MLXIPL LPA	3.38e-03	52	170	3	EFO_0022154
Disease	triglycerides in HDL measurement	APOB MLXIPL LPA	3.56e-03	53	170	3	EFO_0022317
Disease	free cholesterol to total lipids in small LDL percentage	APOB MLXIPL LPA	3.56e-03	53	170	3	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	APOB MLXIPL LPA	3.56e-03	53	170	3	EFO_0022258
Disease	Diabetic Angiopathies	THBS1 NOS3	3.76e-03	16	170	2	C0011875
Disease	Microangiopathy, Diabetic	THBS1 NOS3	3.76e-03	16	170	2	C0025945
Disease	coffee consumption, cups of coffee per day measurement	MLXIPL AHR	3.76e-03	16	170	2	EFO_0004330, EFO_0006782
Disease	sickle cell anemia (is_implicated_in)	APOB NOS3	3.76e-03	16	170	2	DOID:10923 (is_implicated_in)
Disease	total lipids in medium VLDL	APOB MLXIPL LPA	3.76e-03	54	170	3	EFO_0022153
Disease	triglycerides in medium HDL measurement	APOB MLXIPL LPA	3.76e-03	54	170	3	EFO_0022321
Disease	triglycerides in medium VLDL measurement	APOB MLXIPL LPA	3.96e-03	55	170	3	EFO_0022155
Disease	triglycerides in very large HDL measurement	APOB MLXIPL LPA	3.96e-03	55	170	3	EFO_0022324
Disease	triglycerides in large VLDL measurement	APOB MLXIPL LPA	4.16e-03	56	170	3	EFO_0022178
Disease	triglycerides in LDL measurement	APOB MLXIPL LPA	4.16e-03	56	170	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	APOB MLXIPL LPA	4.16e-03	56	170	3	EFO_0022325

Protein segments in the cluster

Peptide	Gene	Start	Entry
FAIATPLQPPSILEI	AHR	266	P35869
RVLFSLVPAPALAPA	EXOC3L1	716	Q86VI1
LPEPISFEAAAIPVA	BACH2	186	Q9BYV9
PTPLRPFVTREVLVE	ADCK2	386	Q7Z695
SLSPEFLRPVPQLRV	LRG1	106	P02750
LAVPFEPARLLPLAA	C8orf82	136	Q6P1X6
VELVPPESPLAQLFL	ASB9	236	Q96DX5
PALPLPVVVAFSRAA	NKAPP1	71	Q8N9T2
QFFLADALILPVPRP	CTC1	691	Q2NKJ3
PPPVELRAAALRAEI	DCTN1	921	Q14203
APARVPTLAVPAISL	DNMT1	6	P26358
VRRFPELQLPVSPSV	CPED1	201	A4D0V7
NLPEESLLRPAYVVP	B4GAT1	306	O43505
PVLSELPEPVVARFI	AEBP1	506	Q8IUX7
DVITIAVPPALPAAL	ATP13A4	436	Q4VNC1
TSPVALQRAIEALPP	ATP7B	306	P35670
LQSFRPLPEPLTVQL	ADAMTS8	776	Q9UP79
SPIDVRVPFPSIQAV	CPA1	61	P15085
PFIPLNFEATPIVRV	EFL1	606	Q7Z2Z2
TITEIPPVIFLPNFL	HDAC11	91	Q96DB2
VTERSAVPFLPVNPE	GIT1	306	Q9Y2X7
TVEDPALQIPPFRIT	AQR	736	O60306
ALQIPPFRITFPVRS	AQR	741	O60306
ARLVFPVTTDPLVPA	RAD54L2	1336	Q9Y4B4
REFQASPLLLPVPTQ	CCDC22	181	O60826
ATLVLNVVPADLRPP	CDHR5	221	Q9HBB8
ARFVSLIPFVPNTPD	CC2D2B	1146	Q6DHV5
FQDSLSPRISVPLIP	DCLRE1B	306	Q9H816
ATPALNLSVRFPIPD	ATG2B	746	Q96BY7
FVVPPVELSINPLAS	ASTN2	601	O75129
QVLNRFSSAPLIPLP	ESRP1	411	Q6NXG1
IFRESPIPIEIPPAA	RC3H1	686	Q5TC82
LAPKVLVFPVFVQPL	RGS3	546	P49796
PEAVLRAEPLNLFRP	ITPRIP	491	Q8IWB1
PPDPLFQRAQVLATS	LRFN5	211	Q96NI6
LAEPPVQFLALETTP	OBSL1	1166	O75147
RLVVRFAPQVEHPTP	NPHS1	831	O60500
PLPEVALPGSFVVRV	DCHS1	481	Q96JQ0
PVNTPIAFFTIRDPE	PCDH20	446	Q8N6Y1
SSVRFVPRDVPLPVV	PBRM1	1081	Q86U86
SVTLRAPEFLPEVPL	KIAA0100	1226	Q14667
SPIRSPQESALLFIP	MICAL3	1156	Q7RTP6
LAVTFLVPRAQPLAP	LRRN4CL	11	Q8ND94
VLPQELQPALTFALP	MADD	271	Q8WXG6
RFPETVPRELVVPVA	EPHB4	206	P54760
FVNVLAEPPRILTPA	NRCAM	446	Q92823
LPVVLPAARREPAVA	DNAAF2	346	Q9NVR5
EPPIVARFVRFIPVT	DDR2	156	Q16832
PRFEILPEGSLRIQP	HMCN2	3731	Q8NDA2
QIPPVLTPLRLDFNF	CFAP65	1161	Q6ZU64
LVAPDTPIQFDIISP	APPL1	446	Q9UKG1
EVARSILREFAFPPP	CBLB	961	Q13191
LPLCVFFRVVPQRLP	FFAR4	171	Q5NUL3
LFNVRLPERLSPVSP	FAT2	1246	Q9NYQ8
GSPVLFAPRPAQVII	FAT2	1846	Q9NYQ8
IPENTLINSRFPIPS	PCDH9	151	Q9HC56
PLQDVPVDAFTPLRI	PDZD7	716	Q9H5P4
PLARLVAPLAPDTQV	PDE2A	131	O00408
PVSLSEFRNPLAPAV	NPRL3	371	Q12980
VLPAERSLFPPVASA	KIAA2012	356	Q0VF49
KVRRTTPVPLFPNEN	LARP6	166	Q9BRS8
VPFAILLAAVPTAPV	MFSD2B	356	A6NFX1
APLFPATVINISIPE	PCDH11X	136	Q9BZA7
PLILPVTQAPIFISF	OXA1L	216	Q15070
EPFPLRVFVNPSLRV	PDF	146	Q9HBH1
NVTLPAVFKAPIRPD	RPL4	21	P36578
EVSPEFLAALPPAIQ	HUWE1	3016	Q7Z6Z7
PLTRLPESFPELQNL	LRRC1	116	Q9BTT6
TPPRLVAPRFLEVET	ICAM3	221	P32942
EQFPSVALPAPLLLT	NOS3	916	P29474
LPVSQLPVFAPLAAA	PRDM6	111	Q9NQX0
ATLTVRAPQPVFREP	OBSCN	3881	Q5VST9
VPPRFVNKVRASPFV	OBSCN	6106	Q5VST9
LFPLPRNGSVPVEIV	PCDHAC1	556	Q9H158
PPAPNSLIRFNAVLT	C1QC	131	P02747
ITLPDFRLPEIAIPE	APOB	2706	P04114
ALDLVTVVVPPALPA	ATP13A2	461	Q9NQ11
ISLISPPAPFLVDAV	EPB41L5	696	Q9HCM4
PSILAELQLREPSFP	HTRA2	371	O43464
LRVLPDVLQVSAAPP	IGSF8	146	Q969P0
TVAPLLPRTLADPFF	KCNA5	311	P22460
PPEHTIVFLVRLLPE	COL20A1	896	Q9P218
QELFPAPILRAVPSA	FCRLA	166	Q7L513
LFRILPDTPQEPFAL	COL14A1	1291	Q05707
FVRADRPPSPVNVTV	FNDC4	41	Q9H6D8
FLPFNRPITTVVGEP	DGAT2L6	276	Q6ZPD8
VFPPNLERPTLAIIG	FMO5	356	P49326
IINRLGRAFIEPPPF	DNAH7	3401	Q8WXX0
PEASIAVVSIPRQLP	SLC3A2	6	P08195
PARPLIFKSPAEIVQ	AKNA	391	Q7Z591
VPPNVILAPSLEAFF	LPA	1026	P08519
PVAVLSSFLTPERLP	MAN2C1	41	Q9NTJ4
FPERITVLDQHLRPP	ATAT1	11	Q5SQI0
PRPAEPITDVAVIAR	DENND4B	41	O75064
LEAAAAREPLVPTFP	ENO4	596	A6NNW6
VPAFTVLQPEGPLAV	FPGS	251	Q05932
PAVVQLLSLPFLPDS	SLC2A9	241	Q9NRM0
DIVPEALFLPRRTPT	CDH6	691	P55285
ELEASAIPPRVVVPL	IGFN1	301	Q86VF2
GVTPPLSPIRFAAQV	DNAJC22	71	Q8N4W6
LPRALAKPAVFIPVN	DHX37	226	Q8IY37
ILPPLIFPATDIDRI	RSC1A1	566	Q92681
PRVLPTSPLDIADFI	CDH15	701	P55291
TFPRFRAIQLEPAEP	MAP3K11	526	Q16584
PVIELVFSVLSPLPV	OR11G2	231	Q8NGC1
EPLVTDVVLQSFPPL	KIF23	466	Q02241
NPVPGLRLTFPEQSV	OAS3	111	Q9Y6K5
VPENFPPGTIIALIS	PCDHGA1	356	Q9Y5H4
VRQVLFPLPTPLSVF	MAP4K1	646	Q92918
APVFRITLPVLAPEV	FUT1	121	P19526
IPFRPVKAVAVDLFP	TRMT2A	561	Q8IZ69
AAPRIVNISVLPSPA	SIGLEC15	166	Q6ZMC9
AIESLPPNIFRFVPL	SLITRK6	171	Q9H5Y7
AIAALELLPRELFPP	PRAME	41	P78395
PAALEPAPVVALVLA	TGFBR3L	261	H3BV60
RISIIPQDPILFPGS	ABCC6	1341	O95255
IPDVLRPIPSALTQA	RFX1	696	P22670
PLDLPQLEIRNSPLF	PKDREJ	276	Q9NTG1
LIVAGLPRFTSQPEP	NEO1	146	Q92859
SPVRTPLEVRLFPQL	PLEKHA7	871	Q6IQ23
AIQDFPTRPLSRFIP	SHLD3	26	Q6ZNX1
PPSRVSVIQFLEAPI	SCRIB	441	Q14160
LPPEAVLVPSDNFTI	IL9R	106	Q01113
LPQERLTSILPENFP	SPATA31C1	436	P0DKV0
QFVERLLPATRIPDP	MRPL49	46	Q13405
PTALLQEEPLFSPRF	MLXIPL	421	Q9NP71
LPPRVDSAQVPLILD	SGCA	371	Q16586
TLIVQPDRVFPPLTS	ARHGAP4	686	P98171
RLVPASAPPARLVEV	RIOX1	121	Q9H6W3
VFRAPEPLELTLPVE	BPIFB2	101	Q8N4F0
LFLTSVVPFVLAPRP	ADAM17	6	P78536
QLLVFTIPIFEPLPS	ASCC3	1251	Q8N3C0
APRTQPDLILVHPVL	SHANK2-AS3	11	Q9BTD1
PFVRPNLPQLLTLAE	TLK1	381	Q9UKI8
STEFRPNAPVPLVID	CTPS2	421	Q9NRF8
SPAFRIEDANLIPPV	THBS1	56	P07996
PALPTLAEIIRLQDP	TNFAIP2	576	Q03169
PVPGLLPAVQRALFV	ZC3H6	656	P61129
LREPVRAPAVAVAPT	RRBP1	96	Q9P2E9
PPVTPIIVLSIINFF	PHTF1	521	Q9UMS5
LDLDVVLIPPPEAFR	SARG	191	Q9BW04
SALQPTPLPFQELRL	SSC4D	46	Q8WTU2
PFLPVLPILSIFVNV	SLC7A1	561	P30825
FLQTRDPPVLPTVSQ	TUT1	441	Q9H6E5
ILDFIRSRPPLNPVS	SPIRE1	341	Q08AE8
IVLEYLRDTPPVPVV	TRPM3	371	Q9HCF6
LAPLINVTEPPRVYV	SRL	276	Q86TD4
FRVPSVEIVTPQLPA	PRX	896	Q9BXM0
VVPVLVFPPDLVFRA	MOSPD3	31	O75425
DRVVFPTITLVPPVL	TMEM104	396	Q8NE00
PNAGPLFRVPITAVI	TPP2	621	P29144
DSVFPLQSVVDRPPV	ZDBF2	541	Q9HCK1
VISPPLSVIVPEFER	ZDBF2	2061	Q9HCK1
LPRSVPVVPSFVAND	TTC3	1361	P53804
RPPETARTEPVVLVF	NDST2	76	P52849
PPLFIPDNIATIRRE	PHF3	686	Q92576
LVLTGPPNFRPALVD	SLC12A3	646	P55017
APKIRAEQISPFFPL	TEX10	126	Q9NXF1
FTEVLQAPAIRIPPS	PPP1R3F	406	Q6ZSY5
ATLTVRAPPQFVVRP	ROBO2	306	Q9HCK4
ILAESPPPARLDIQL	TRIM72	251	Q6ZMU5
NPPIARFLLPLERIS	nan	56	Q5XG85
LHLPPEIVPASLQRV	PLEC	86	Q15149
LAQPPLLLPAESVDV	SUCO	661	Q9UBS9
FPPVRQIVLEGLRSP	TET3	621	O43151
VIRCPVRANPPLLFV	IGSF9	341	Q9P2J2
DLLVIATPAQLDPRP	TTLL6	796	Q8N841
TRPPIIDAPALALAQ	CAD	1506	P27708
PVLESLALEVPAQLP	TXNDC11	426	Q6PKC3
TIVIRPPFLRPEVSD	ZDHHC5	261	Q9C0B5
PVSPLVRFQLPNVLF	ZNHIT2	206	Q9UHR6
SLPAIVRPEFPRQSV	VPS13B	3201	Q7Z7G8
VRPEFPRQSVAVPLG	VPS13B	3206	Q7Z7G8
EFSIVVTLRVPNLPP	TSPEAR	86	Q8WU66
IVPNAPATIPLLAVA	WNK2	876	Q9Y3S1
IPPGAVITRAPVLFQ	ZSCAN29	546	Q8IWY8
IFAQPAARPVAIPNT	TUT4	1531	Q5TAX3
PATLYAVVENVPPLR	TNFRSF1A	356	P19438
PVPFRLTPNISEFLT	TRRAP	3726	Q9Y4A5
LFSRVLLVDFQPAPP	TRPM4	796	Q8TD43
RQLAVLTELPFVVPF	UBE3C	681	Q15386
SLVFEPLPPLRIVES	UNC79	1631	Q9P2D8
DTPVPLPFFVRTANQ	HECTD3	561	Q5T447
IPRTVPPDVISLSFV	LGI1	61	O95970